Palmitoylethanolamide (PEA) CAS 544-31-0: Comprehensive User Guide
Table of Contents
- 1. Product Overview & Specifications
- 2. Key Applications & Mechanisms
- 3. Usage Guidelines & Best Practices
- 4. Industry Application Cases
- 5. Verified Customer Success Stories
- 6. Request Customized Solutions
1. Product Overview & Specifications
| Parameter | PEA (Palmitoylethanolamide) | Common Alternatives |
|---|---|---|
| CAS Number | 544-31-0 | N/A |
| Purity | ≥99% (HPLC) | 90-95% |
| Molecular Formula | C₁₈H₃₇NO₂ | Varies |
| Solubility | Lipophilic | Water-soluble derivatives |
2. Key Applications & Mechanisms
Primary Therapeutic Actions:
- Neuropathic pain modulation via PPAR-α activation
- Mast cell stabilization for inflammatory response control
- Endocannabinoid system enhancement
3. Usage Guidelines & Best Practices
Formulation Considerations:
| Delivery System | Bioavailability | Recommended Use |
|---|---|---|
| Micronized PEA | 58-62% | Oral supplements |
| Liposomal | 78-82% | Topical formulations |
4. Industry Application Cases
Pharmaceutical Development:
- Chronic pain management tablets (300mg PEA/capsule)
- Ophthalmic solutions for inflammatory eye conditions
5. Verified Customer Success Stories
Case Study 1: European Nutraceutical Manufacturer
- Application: 600mg/day PEA in neurosupport supplements
- Result: 40% reduction in customer pain complaints
Case Study 2: US Veterinary Products Company
- Application: Canine joint health formulas
- Result: 35% improvement in mobility metrics
6. Request Customized Solutions
Contact our technical team for formulation support:
Email: info@vivalr.com
Tel: (86) 15866781826



评论
目前还没有评论。